Abstract
This study aimed to investigate the role of src-homology protein tyrosine phosphatase-1 (SHP-1)-signal transducer and activator of transcription 3 (STAT3) pathway in liver fibrogenesis and the anti-fibrotic effect of SHP-1 agonist. The antifibrotic activity of SC-43, a sorafenib derivative with an enhanced SHP-1 activity, was evaluated in two fibrosis mouse models by carbon tetrachloride induction and bile duct ligation. Rat, human, and primary mouse hepatic stellate cells (HSCs) were used for mechanistic investigations. The results showed that SHP-1 protein primarily localized in fibrotic areas of human and mouse livers. SC-43 treatment reduced the activated HSCs and thus effectively prevented and regressed liver fibrosis in both fibrosis mouse models and improved mouse survival. In vitro studies revealed that SC-43 promoted HSC apoptosis, increased the SHP-1 activity and inhibited phospho-STAT3. The enhanced SHP-1 activity in HSCs significantly inhibited HSC proliferation, whereas SHP-1 inhibition rescued SC-43-induced HSC apoptosis. Furthermore, SC-43 interacted with the N-SH2 domain of SHP-1 to enhance the activity of SHP-1 as its antifibrotic mechanism. In conclusion, the SHP-1-STAT3 pathway is crucial in fibrogenesis. SC-...Continue Reading
References
Jun 1, 1997·American Journal of Epidemiology·M W YuY F Liaw
Dec 17, 2002·The Journal of Biological Chemistry·Jian YangG Wayne Zhou
Mar 27, 2003·Gene·Chengyu WuG Wayne Zhou
Jul 25, 2007·Histology and Histopathology·Z Z Chong, K Maiese
Dec 7, 2007·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·W G ShinC K Park
Nov 3, 2009·Nature Medicine·Pedro GeraldesGeorge L King
Oct 5, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kuen-Feng ChenAnn-Lii Cheng
Feb 5, 2011·Anti-cancer Agents in Medicinal Chemistry·Pilar López-RuizBegoña Colás
Mar 1, 2011·Journal of Hepatology·Wei-Tien TaiKuen-Feng Chen
Apr 6, 2011·Journal of Cellular Biochemistry·Wei WangG Wayne Zhou
May 3, 2011·European Journal of Medicinal Chemistry·Kuen-Feng ChenChung-Wai Shiau
May 10, 2011·International Journal of Biological Sciences·Hua WangBin Gao
May 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Tatiana KisselevaDavid A Brenner
Jan 11, 2013·Science Translational Medicine·Scott L FriedmanShelia Violette
Aug 3, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Wei-Tien TaiKuen-Feng Chen
Oct 22, 2013·Biochimica Et Biophysica Acta·Elena TibaldiAnna Maria Brunati
Nov 23, 2013·Reviews in Endocrine & Metabolic Disorders·Elaine XuAndré Marette
Jun 14, 2014·International Journal of Molecular Sciences·Tung-Hung SuChun-Jen Liu
Sep 23, 2014·Expert Review of Gastroenterology & Hepatology·Tung-Hung Su, Jia-Horng Kao
Jan 27, 2015·Oncogene·L-C FanK-F Chen
Jun 4, 2015·Proceedings of the National Academy of Sciences of the United States of America·Tung-Hung SuDing-Shinn Chen
Jul 25, 2015·Journal of the National Cancer Institute·Sheng-Han WangPei-Jer Chen
Apr 6, 2016·FEBS Open Bio·Janine KrügerKai Kappert
Sep 17, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Tung-Hung SuUNKNOWN C-TEAM study group and the Taiwan Liver Diseases Consortium